A ketamine clinic carries two compliance problems most wellness practices never face: a Schedule III controlled substance and an IV-administered treatment. Federal scheduling triggers DEA registration, recordkeeping, and storage rules the moment your physician writes the first order. The infusion itself keeps a patient sedated for 30 to 60 minutes, which demands active monitoring, not a signature on a protocol binder. Your medical director has to cover both sides at once.

Why Ketamine Clinics Require Heightened Physician Oversight

Ketamine clinics answer to two compliance questions at once instead of one: what the prescriber authorizes, and what happens to the patient during the infusion. Ketamine’s Schedule III status governs the first question, and the IV route governs the second. Each carries separate rules, and both apply from the day your clinic sees its first patient.

• Prescribing authority: A DEA-registered prescriber must authorize every dose, and your clinic must store and track ketamine under federal recordkeeping rules built for controlled substances.
• Infusion monitoring: Ketamine at subanesthetic doses can affect blood pressure, heart rate, and mental status, so a trained clinician has to stay in the room with monitoring equipment rather than a signed consent form.
• Comparable standard: This active-monitoring requirement mirrors IV hydration clinics, another infusion-based service where a present clinician matters more than paperwork.

A medical director who reviews only the prescribing side, or only the monitoring side, leaves half your clinic’s real risk unaddressed.

Controlled Substance and DEA Considerations for Ketamine

Ketamine’s Schedule III classification is federal, so it applies the same way regardless of your clinic’s state or the reason for treatment. That single classification drives the DEA paperwork your medical director must keep current. Getting it wrong usually means one of two mistakes: treating registration as optional, or treating it as a one-time task.

• Registration requirement: Every practitioner who prescribes, administers, or dispenses ketamine needs an active DEA registration covering Schedule III substances, regardless of the treatment indication.
• Facility registration: A facility that stores ketamine in its own inventory generally needs its own DEA registration, with storage meeting the security standard in 21 CFR 1301.75, a securely locked, substantially constructed cabinet, and dispensing records tracking every dose.
• Shared classification: Ketamine shares its Schedule III tier with testosterone, which is why our medical director requirements for male sexual health and TRT clinics coverage flags the same registration step for hormone clinics.

The DEA has also signaled closer attention to ketamine prescribing following several high-profile cases tied to off-label use, so registration deserves an ongoing program, not a filed form.

Patient Screening and Monitoring Protocols

Ketamine’s effect on the cardiovascular and nervous systems makes patient screening a clinical necessity, not a formality. Screening happens before the infusion starts, monitoring happens during the infusion, and discharge criteria determine when the patient leaves. Each stage requires specific checks.

• Pre-infusion screening: A clinician should review the patient’s cardiac history, blood pressure, psychiatric history, and any interacting medications, since uncontrolled hypertension and certain psychotic disorders are commonly listed cautions in ketamine treatment literature.
• Active monitoring: Staff should check blood pressure, heart rate, and oxygen saturation at set intervals throughout the infusion, with a trained clinician staying nearby to catch an adverse reaction early.
• Discharge criteria: Patients must return to baseline mental status and have stable vital signs before leaving the clinic.

Your medical director should hold Advanced Cardiac Life Support certification, or confirm the clinical staff does, since sedation-related complications can escalate quickly.

State-by-State Requirements for Ketamine Clinics

Federal scheduling sets the floor for ketamine clinic oversight, and individual states add requirements on top of it. A rule that applies under one state’s medical board may not exist in another. That variation is why no single national answer works for every clinic.

• Administration and supervision: State medical boards can set who may administer ketamine and what supervision a nurse practitioner or physician assistant needs.
• Telehealth prescribing: Some states require an in-person relationship before ketamine can be prescribed through telehealth.
• Facility accreditation: Some states fold ketamine clinics into rules written for office-based anesthesia, which can trigger facility accreditation that a standalone medspa never faces.

A medical director familiar with your specific state avoids the common trap of applying a neighboring state’s rule to the wrong jurisdiction, so confirm your current state requirement before finalizing protocols.

How Medical Director Co. Places Ketamine Clinic Medical Directors

Medical Director Co. matches ketamine clinics with physicians who already have ketamine infusion protocol experience, rather than physicians learning the drug’s requirements on the job. Ketamine placement runs through the same medical director and collaborating physician services Medical Director Co. offers across 40-plus clinic types. Placement typically happens within 24 hours of intake, and plans start at $799 a month with no long-term contract. The agreement covers DEA-compliant protocol review, chart review cadence, and the physician availability your clinic needs for emergency consultation during infusion hours.